• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

9至11岁儿童通用血脂筛查的质量改进干预措施。

Quality Improvement Intervention for Universal Lipid Screening in Children Aged 9 to 11 Years.

作者信息

Stipelman Carole H, Stoddard Gregory J, Smith Elizabeth R, Bell Jamie J, Sivaloganathan Vasee, Liu Diane, Goldman-Luthy Jennifer A, Nguyen Quang-Tuyen, Rivero Andrea, Burgi Jennifer R, Young Paul C

机构信息

University of Utah, Salt Lake City, UT, USA.

University of Utah Hospitals and Clinics Enterprise Data Warehouse, Salt Lake City, UT, USA.

出版信息

Clin Pediatr (Phila). 2019 Dec;58(14):1528-1533. doi: 10.1177/0009922819884403. Epub 2019 Oct 22.

DOI:10.1177/0009922819884403
PMID:31640403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10498961/
Abstract

We performed a quality improvement intervention to increase universal lipid screening in well-child visits (age 9 to 11 years): 12-month preintervention; phase 1 (8 months) with provider education, group monthly chart review with feedback, and electronic health record cues to order lipids; and phase 2 (16 months) with electronic health record cues and examination room phlebotomy. Outcomes were compared with clinics having no intervention. In phase 1, immediate treatment effect on the regression line for provider behavior (proportion of visits with lipids ordered) showed 34% increase in intervention and 7% decrease in comparison clinics; patient behavior (phlebotomy completed) showed 19% increase in intervention and 5% decrease in comparison clinics. At the beginning of phase 2, the intervention clinic had average 44% orders entered and 33% phlebotomy completed per well-child visit, and these proportions were maintained. Provider education and chart review with feedback were associated with the greatest gains in outcomes.

摘要

我们开展了一项质量改进干预措施,以提高健康儿童(9至11岁)就诊时的血脂普遍筛查率:干预前12个月;第一阶段(8个月)进行提供者教育、每月小组病历审查并给予反馈,以及利用电子健康记录提示来开具血脂检查医嘱;第二阶段(16个月)利用电子健康记录提示并在检查室进行静脉采血。将结果与未进行干预的诊所进行比较。在第一阶段,对提供者行为(开具血脂检查医嘱的就诊比例)的回归线的即时治疗效果显示,干预组增加了34%,而对照诊所减少了7%;患者行为(完成静脉采血)显示,干预组增加了19%,对照诊所减少了5%。在第二阶段开始时,干预诊所每次健康儿童就诊的血脂检查医嘱录入平均为44%,静脉采血完成率为33%,且这些比例得以维持。提供者教育和带反馈的病历审查与结果的最大改善相关。

相似文献

1
Quality Improvement Intervention for Universal Lipid Screening in Children Aged 9 to 11 Years.9至11岁儿童通用血脂筛查的质量改进干预措施。
Clin Pediatr (Phila). 2019 Dec;58(14):1528-1533. doi: 10.1177/0009922819884403. Epub 2019 Oct 22.
2
A cluster-randomized trial to estimate the effect of mobile screening and treatment feedback on HbA1c and diabetes-related complications in Tshwane primary health care clinics, South Africa.一项整群随机试验,旨在评估南非茨瓦内初级卫生保健诊所的移动筛查及治疗反馈对糖化血红蛋白(HbA1c)和糖尿病相关并发症的影响。
Prim Care Diabetes. 2017 Dec;11(6):546-554. doi: 10.1016/j.pcd.2017.05.010. Epub 2017 Jul 6.
3
Effect of a clinical practice improvement intervention on Chlamydial screening among adolescent girls.临床实践改进干预措施对青春期女孩衣原体筛查的影响。
JAMA. 2002 Dec 11;288(22):2846-52. doi: 10.1001/jama.288.22.2846.
4
A pilot quality improvement program to increase pediatrician injury anticipatory guidance.一项旨在加强儿科医生伤害预防指导的试点质量改进项目。
J Trauma Acute Care Surg. 2015 Sep;79(3 Suppl 1):S9-14. doi: 10.1097/TA.0000000000000672.
5
Screenings during Well-Child Visits in Primary Care: A Quality Improvement Study.儿童保健常规就诊中的筛查:一项质量改进研究。
J Am Board Fam Med. 2018 Jul-Aug;31(4):558-569. doi: 10.3122/jabfm.2018.04.170222.
6
Increasing Universal Lipid Screening Among 9- to 11-Year-Old Children Through a Quality Improvement Initiative.通过质量改进计划增加9至11岁儿童的普遍血脂筛查。
Clin Pediatr (Phila). 2017 Jun;56(7):640-647. doi: 10.1177/0009922816670979. Epub 2016 Sep 23.
7
Outcomes of Implementing Routine Screening and Referrals for Perinatal Mood Disorders in an Integrated Multi-site Pediatric and Obstetric Setting.在综合性多站点儿科和产科环境中实施围产期情绪障碍常规筛查和转介的结果。
Matern Child Health J. 2019 Oct;23(10):1292-1298. doi: 10.1007/s10995-019-02780-x.
8
Updated guidelines for lipid screening in children and adolescents.儿童和青少年血脂筛查更新指南。
JAAPA. 2015 Mar;28(3):30-6. doi: 10.1097/01.JAA.0000460916.60015.88.
9
Improving Universal Pediatric Lipid Screening.改善儿童血脂全面筛查。
J Pediatr. 2017 Sep;188:87-90. doi: 10.1016/j.jpeds.2017.05.030. Epub 2017 Jun 5.
10
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.

引用本文的文献

1
Improved Adherence to Lipid Screening in the Pediatric Cardiology Clinic: A Quality Improvement Project.儿科心脏病诊所脂质筛查依从性的改善:一项质量改进项目。
Pediatr Qual Saf. 2024 Dec 24;10(1):e781. doi: 10.1097/pq9.0000000000000781. eCollection 2025 Jan-Feb.
2
Universal Lipid Screening Among 9- to 11-Year-Old Children: Screening Results and Physician Management.9 至 11 岁儿童的普遍血脂筛查:筛查结果和医生管理。
Clin Pediatr (Phila). 2022 Mar;61(3):280-288. doi: 10.1177/00099228221075409. Epub 2022 Jan 28.
3
Improving Compliance with Dyslipidemia Screening Guidelines in a Single-center U.S. Outpatient Pediatric Cardiology Clinic.提高美国一家单中心门诊儿科心脏病诊所对血脂异常筛查指南的依从性。
Pediatr Qual Saf. 2021 May 5;6(3):e401. doi: 10.1097/pq9.0000000000000401. eCollection 2021 May-Jun.

本文引用的文献

1
Trends and Patterns of Geographic Variation in Cardiovascular Mortality Among US Counties, 1980-2014.1980 - 2014年美国各县心血管疾病死亡率的地理差异趋势与模式
JAMA. 2017 May 16;317(19):1976-1992. doi: 10.1001/jama.2017.4150.
2
Cholesterol Screening and Treatment Practices and Preferences: A Survey of United States Pediatricians.胆固醇筛查与治疗实践及偏好:美国儿科医生的一项调查
J Pediatr. 2017 Jun;185:99-105.e2. doi: 10.1016/j.jpeds.2016.12.078. Epub 2017 Feb 13.
3
Dyslipidemia Screening of 9- to 11-Year-Olds at Well-Child Visits by Utah Pediatricians.
Clin Pediatr (Phila). 2017 Dec;56(14):1286-1290. doi: 10.1177/0009922816684601. Epub 2016 Dec 22.
4
Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.儿童和青少年血脂异常筛查:美国预防服务工作组推荐声明。
JAMA. 2016 Aug 9;316(6):625-33. doi: 10.1001/jama.2016.9852.
5
Lipid Screening in Children and Adolescents.儿童和青少年的血脂筛查
JAMA. 2016 Aug 9;316(6):589-91. doi: 10.1001/jama.2016.9671.
6
Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES).1999 年至 2012 年美国国家健康和营养调查(NHANES)中家族性高胆固醇血症的流行情况。
Circulation. 2016 Mar 15;133(11):1067-72. doi: 10.1161/CIRCULATIONAHA.115.018791.
7
Physicians' Lack of Adherence to National Heart, Lung, and Blood Institute Guidelines for Pediatric Lipid Screening.医生未遵循美国国立心肺血液研究所的儿科血脂筛查指南。
Clin Pediatr (Phila). 2015 Oct;54(12):1200-5. doi: 10.1177/0009922815576885. Epub 2015 Mar 26.
8
Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999-2012.1999 - 2012年美国儿童及青少年血脂异常和血压的患病率及趋势
JAMA Pediatr. 2015 Mar;169(3):272-9. doi: 10.1001/jamapediatrics.2014.3216.
9
Lipid screening in children and adolescents in community practice: 2007 to 2010.2007年至2010年社区实践中儿童和青少年的血脂筛查
Circ Cardiovasc Qual Outcomes. 2014 Sep;7(5):718-26. doi: 10.1161/CIRCOUTCOMES.114.000842. Epub 2014 Aug 26.
10
2014 recommendations for pediatric preventive health care.2014年儿童预防性医疗保健建议。
Pediatrics. 2014 Mar;133(3):568-70. doi: 10.1542/peds.2013-4096. Epub 2014 Feb 24.